Monday, May 27, 2024
- Advertisement -
HomeProvincial NewsArmy captures, treats wounded rebel

Army captures, treats wounded rebel

- Advertisement -

Army troops have captured a wounded member of the New People’s Army, which is one of those involved in recent clash in Guihulngan.

He is currently being treated and in stable condition.

Last 23 March 2021, troopers of the 62nd Infantry Battalion, 33rd Division Reconnaissance Company (33DRC) and 16th Scout Ranger Company clashed against 40 members of Leonardo Panaligan Command – New People’s Army in Sitio Agit, village of Trinidad, Guihulngan City, Negros Oriental.

- Advertisement -

The army confirmed that 10 rebels were killed, while one was wounded. The wounded rebel is now under government custody and is being treated.

As this developed, the 62nd IB Commanding Officer Lt. Col. Melvin Flores expressed sympathies with the families of the slain rebels who “have suffered so much because of the selfishness of the NPA leaders who took advantage of our brothers”.

“Once again we are calling on the remaining NPAs, to surrender now along with your firearms and avail the Enhanced Comprehensive Local Integration Program or E-CLIP of our government, but if you don’t, we don’t have a choice but to do our duty to enforce the full force of the law and protect the people”, he added.

- Advertisement -

The three-hour clash yielded 11 high-powered firearms, namely five M16s, two M14s, two M4 rifles, one) M60 machine gun and one KG9 assault pistol; magazines with live ammunitions; improvised Explosive Device (IED) wires; medicines including anti-pregnancy pills, backpacks, personal belongings and other documents.

- Advertisement -
Hannah A. Papasin
Hannah A. Papasinhttp://facebook.com/hannah.mariveles
Writer. Critic. Professor. She started writing since primary school and now has two published textbooks on communication. A film buff, she's a Communication, Media Literacy and Journalism Professor of the University of St. La Salle-Bacolod, and has a Master's Degree in English.
- Advertisment -


- Advertisement -